Stocks · Health care · Services-Commercial Physical & Biological Research

OmniAb, Inc.

OABI Clue Score25
United States Fiscal year ends December CIK 0001846253 Results filed 30 Oct 2026

What the insiders did Net buying

By person

13 insiders · 64 transactions
10.6×

Matthew W. Foehr holds 10.6 times base salary in stock. $6.59M of shares against $620.87K in salary for 2025.

Salary from the company's own proxy. The shares are what Matthew W. Foehr last reported holding, valued at $1.49, the price Common Stock was last bought or sold at on the open market here, on 7 Apr 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Matthew W Foehr
President and CEO
$7.76M (10)
$497.06K (9)
+$7.27M
4,420,492
3.04%
$6.59M
—
Kurt A Gustafson
Executive VP, Finance and CFO
$28.10K (1)
$404.32K (11)
−$376.22K
261,483
0.1798%
$389.61K
—
Charles S Berkman
Chief Legal Officer
—
$278.49K (10)
−$278.49K
399,085
0.2745%
$594.64K
—
John L Higgins
Director
$505.94K (5)
$235.00K (3) scheduled
+$270.94K
2,962,320
2.04%
$4.41M
+6,574%
Jennifer R. Cochran
Director
$222.05K (3)
—
+$222.05K
185,274
0.1274%
$276.06K
—
Sunil Patel
Director
$119.11K (1)
—
+$119.11K
224,265
0.1543%
$334.15K
—
Sarah Boyce
Director
$101.40K (2)
—
+$101.40K
104,381
0.0718%
$155.53K
+4,664%
Steven Love
Director
$36.50K (1)
—
+$36.50K
105,000
0.0722%
$156.45K
—
Avista Capital Managing Member V, LLC entity
10% owner
—
—
—
15,862,815
10.91%
$23.64M
+0.6%
Avista Acquisition GP LLC II entity
Director
—
—
—
8,534,450
5.87%
$12.72M
—
Carolyn R Bertozzi
Director
—
—
—
113,308
0.0779%
$168.83K
—
Steven C. Crouse
Director
—
—
—
33,333
0.0229%
$49.67K
—
Philip J Gotwals
Director
—
—
—
33,333
0.0229%
$49.67K
—